Medicare AdvantageCoverageMedium impact
MA07.032a, Tumor Treating Fields
Independence Blue Cross·Oncology, Radiation Oncology·Medical Policy
Effective date
Jul 22, 2026
We identified it
Jul 23, 2026
Summary
Medicare Advantage policy MA07.032a regarding Tumor Treating Fields has been reissued effective 07/22/2026. The full policy details are not provided in the source material, so specific coverage changes, billing code impacts, and prior authorization requirements cannot be determined from this announcement alone. The billing team must access the complete policy document to identify actionable changes.
Action Required
By 07/22/2026: Billing team must obtain and review the complete MA07.032a policy document from the source URL (https://medpolicy.ibx.com/ibc/ma/Pages/Site-Activity-View.aspx?FilterField1=MPSiteActivityLogMonth&FilterValue1=07&FilterField2=MPSiteActivityLogYear&FilterValue2=2026). Once the full policy is reviewed, identify: (1) specific CPT/HCPCS codes affected, (2) prior authorization requirements, (3) coverage criteria for Tumor Treating Fields devices, and (4) any documentation requirements. Update billing system, encounter templates, and provider guidance accordingly. Coordinate with oncology providers to ensure compliance with new requirements. Claims submitted after 07/22/2026 that do not comply with updated policy may be denied.